Stock UniverseDerived research view · source repositories remain read-only

Pfizer Inc. (PFE)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - General
Score Band
Qualified
Selection Score
35.80
Global Rank
1124
Market Cap
157.23B
Latest Close
26.04
RS Composite
-6.01% · G#1821

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-0.23%
3M
-2.14%
6M
5.25%
1Y
19.11%
3Y
-17.46%
5Y
-13.13%
10Y
23.46%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 31.75M · 30-day average: 36.02M · Max drawdown over stored range: -58.96%

Research Snapshot

Relative Strength vs SPX

RS Composite-6.01%
20D RS-0.67%
60D RS-12.01%
120D RS-2.68%
Global RS Rank1821 · 45.72% percentile
Qualified+ RS Rank667 · 46.98% percentile
Group ScopeQualified+
Primary RS Rank175 · 61.79% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank184 / 701
Primary Percentile73.89
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-292026-05-0563.31Bn/an/a7.49B1.3116.07B4.25B11.82B5,718Mn/an/a11.83%25.38%18.68%1.70B60.56B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-29$1.3119.9x$11.072.4x$2.0712.6x$2.819.3x

Shares Diluted: 5,718M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue81288101175595536362762579
Revenue Growth (YoY)95.165%24.465%-41.139%6.841%-1.647%
Gross Profit5060267078417644720747439
Operating Income2698039841125161632819163
Free Cash Flow2986926031479398350
Free Cash Flow Per Share5.2334.5410.841.72538
EPS (Diluted) GAAP3.8539665.4710460.3673721.4119291.364375
EPS Growth136.579%41.959%-93.285%284.332%-3.368%
EPS Non-GAAP
Gross Margin62.25%66.299%70.129%74.193%75.807%
Operating Margin33.191%39.378%21.017%25.662%30.622%
Profit Margin27.038%31.008%3.558%12.622%12.418%
Free Cash Flow Margin36.745%25.729%8.048%15.457%3800%
Shares Outstanding (Diluted)57085733570957005713
Shares Change (YoY)1.349%0.438%-0.419%-0.158%0.228%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0514.45Bn/an/an/a2.69B18.59%0.475.73B1.70B60.56Bprocessed
2025 Q42026-02-2617.56Bn/an/an/a-1.65B-9.39%-0.295.72B1.14B61.64Bprocessed
2025 Q32025-11-0416.65Bn/an/an/a3.54B21.26%0.625.71B1.34B57.41Bprocessed
2025 Q22025-08-0514.65Bn/an/an/a2.91B19.86%0.515.71B1.64B57.50Bprocessed
2025 Q12025-05-0513.71Bn/an/an/a2.97B21.63%0.525.71B1.43B57.64Bprocessed
2024 Q42025-02-2717.76B12.79%n/an/a410.00M2.31%0.075.70B1.04B57.41Bprocessed
2024 Q32024-11-0417.70B12.19%n/an/a4.46B25.22%0.785.71B1.09B58.00Bprocessed
2024 Q22024-08-0513.28B17.53%n/an/a41.00M0.31%0.015.70B1.05B57.51Bprocessed
2024 Q12024-05-0814.88B12.35%n/an/a3.12B20.94%0.555.70B719.00M61.31Bprocessed
2023 Q42024-02-226.67B32.59%n/an/a-3.37B-50.53%-0.595.69B2.85B61.54Bprocessed
2023 Q32023-11-0813.23B16.38%n/an/a-2.38B-18.00%-0.425.65B3.15B61.05Bprocessed
2023 Q22023-08-0912.73B17.55%n/an/a2.33B18.27%0.415.71B2.63B61.36Bprocessed
2023 Q12023-05-1018.28B9.66%n/an/a5.54B30.32%0.975.73B2.17B31.70Bprocessed
2022 Q42023-02-2324.29B8.86%n/an/a4.99B20.56%0.875.75B416.00M32.88Bprocessed
2022 Q32022-11-0922.64B8.93%n/an/a8.61B38.02%1.515.72B1.30B32.63Bprocessed
2022 Q22022-08-1027.74B7.94%n/an/a9.91B35.71%1.735.71B1.78B34.29Bprocessed
2022 Q12022-05-1125.66B8.21%n/an/a7.86B30.65%1.375.76B2.47B35.66Bprocessed
2021 Q42022-02-2423.64B9.26%n/an/a3.39B14.36%0.595.77B1.94B36.20Bprocessed
2021 Q32021-11-1224.09B8.18%n/an/a8.15B33.81%1.425.72B29.70B36.25Bprocessed
2021 Q22021-08-1218.98B10.60%n/an/a5.56B29.31%0.985.68B21.70B35.35Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.